Wikipedia -WSS

Wikipedia

author：focus 2025-08-11 07:59:01 - browse：52

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The Harvard botanist who searched for psychedelics in the Amazon

explore

WSS

He's a Nobel laureate. Critics say he was misleading on Covid

NIH study of ME/CFS points to clear biological hallmarks

Use wet bulb globe temperature, not heat index, to protect workers

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Sanofi strikes deal with Novavax, boosting the vaccine maker

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Medical records are filled with copy

Study: Adult vaccinations pay for themselves in societal benefits

BioMarin wins approval for gene therapy to treat hemophilia A

Dairy farmers resist CDC push for PPE against bird flu virus

Medicare proposal to cover medical devices draws a mixed reaction

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

As demand for Covid shots wanes, Moderna seeks its next success

With competition flaring, obesity drug hits goal in liver disease study

Supreme Court strikes down use of affirmative action

H5N1 bird flu: what we're starting to learn about infection in cows

hotspot

Steward Health Care files for bankruptcy

Community Health Systems hospitals under DOJ investigation

Alabama frozen embryo ruling has major implications for IVF clinics

H5N1 communication has been strictly for the birds

NIH study of ME/CFS points to clear biological hallmarks

Elevance, private equity launch primary care company

explore

Wikipedia

Wikipedia

Wikipedia